Nghĩa của từ alethia bằng Tiếng Việt

@Chuyên ngành kỹ thuật
@Lĩnh vực: y học
-không có khả năng quê

Đặt câu có từ "alethia"

Dưới đây là những mẫu câu có chứa từ "alethia", trong bộ từ điển Từ điển Anh - Việt. Chúng ta có thể tham khảo những mẫu câu này để đặt câu trong tình huống cần đặt câu với từ alethia, hoặc tham khảo ngữ cảnh sử dụng từ alethia trong bộ từ điển Từ điển Anh - Việt

1. Aboard the sailing vessel Alethia.

2. CIHR $413K, Alethia Biotherapeutics (Montreal) $834K (includes cash and in-kind contributions)

3. Two provisional patents, one published patent, one commercial license and one biotechnology company started Alethia BioTherapeutics

4. CIHR $413K, Alethia Biotherapeutics (Montreal) $834K (includes cash and in-kind contributions) CIHR Spin-off Success Story Neuromed:

5. We work closely with a new company, Alethia BioTherapeutics, which was created especially to speed the practical use of our research.

6. Alethia, a West African who has served in the full-time service for 30 years in her native country, said this: “I had the opportunity to live abroad.

7. As part of the CIHR/SME Research program, Montreal-based Alethia BioTherapeutics has partnered with a research team at the Centre hospitalier de l’Université de Montréal to develop new treatments for ovarian cancer.

8. As part of the CIHR/SME Research Program, Montreal-based Alethia BioTherapeutics has partnered with a research team at the Centre Hosp. de l'Université de Montréal to develop new treatments for ovarian cancer.

9. With CIHR support, Dr. Anne-Marie Mes-Masson of the Centre Hospitalier de l’Université de Montréal (CHUM) has identified genes that are associated with aggressive ovarian cancer and is working with Alethia BioTherapeutics in Montreal to identify which of these genes are good targets for drug development and to take these candidates the next step forward.

10. With CIHR support, Dr. Anne-Marie Mes-Masson of the Centre Hospitalier de l'Université de Montréal (CHUM) has identified genes that are associated with aggressive ovarian cancer and is working with Alethia BioTherapeutics in Montreal to identify which of these genes are good targets for drug development and to take these candidates the next step forward.